Magnolia Medical Technologies
Developer of clinical solutions and services to reduce blood culture contamination and improve sepsis diagnostic accuracy. Core activities described on the site include an initial specimen diversion device for blood culture collection (evidence-backed and FDA 510(k)-cleared), clinical evidence generation and validation, diagnostic stewardship analytics and educational/quality-improvement programs targeted to hospitals and laboratories.
Industries
Nr. of Employees
medium (51-250)
Magnolia Medical Technologies
Seattle, Washington, United States
Patents
Systems and methods for delivering a fluid to a patient with reduced contamination
US-9931466-B2
View Details
Systems and methods for delivering a fluid to a patient with reduced contamination
US-9931466-B2
View DetailsProducts
Initial specimen diversion device for blood culture collection
A medical device intended for use during blood culture collection to divert and discard the initial portion of the draw (which may contain skin contaminants) before inoculating culture media. Offered in configurations compatible with direct-to-media collection and syringe draws.
Initial specimen diversion device for blood culture collection
A medical device intended for use during blood culture collection to divert and discard the initial portion of the draw (which may contain skin contaminants) before inoculating culture media. Offered in configurations compatible with direct-to-media collection and syringe draws.
Services
Analytics service to streamline data capture and quantify clinical and economic impact of interventions that reduce sepsis misdiagnosis and blood culture contamination.
Webinars, training programs, and multidisciplinary quality-improvement resources to implement evidence-based blood culture collection practices and reduce contamination.
Analytics service to streamline data capture and quantify clinical and economic impact of interventions that reduce sepsis misdiagnosis and blood culture contamination.
Webinars, training programs, and multidisciplinary quality-improvement resources to implement evidence-based blood culture collection practices and reduce contamination.
Expertise Areas
- Diagnostic stewardship
- Clinical microbiology
- Blood culture collection and contamination prevention
- Clinical evidence generation and validation
Key Technologies
- Initial specimen diversion devices (ISDD)
- Blood culture collection protocols and antisepsis methods
- Clinical trial and real-world evidence methodologies
- Healthcare data capture and analytics platforms
News & Updates
Regulatory clearance granted for an initial specimen diversion device product family with indication to reduce blood culture contamination.
Introduction of a data capture and analytics service to measure clinical and economic outcomes related to contamination reduction and sepsis diagnostic accuracy.
Announcement of a commercial collaboration to expand distribution and market access for the blood culture diversion device.
Publication reporting multiple patient harms associated with blood culture contamination, including increased in-hospital mortality risk.
Case study reporting zero blood culture contaminations and near elimination of false-positive central line-associated bloodstream infections in a large-scale study using an initial specimen diversion device.
Regulatory clearance granted for an initial specimen diversion device product family with indication to reduce blood culture contamination.
Introduction of a data capture and analytics service to measure clinical and economic outcomes related to contamination reduction and sepsis diagnostic accuracy.
Announcement of a commercial collaboration to expand distribution and market access for the blood culture diversion device.
Publication reporting multiple patient harms associated with blood culture contamination, including increased in-hospital mortality risk.
Case study reporting zero blood culture contaminations and near elimination of false-positive central line-associated bloodstream infections in a large-scale study using an initial specimen diversion device.